Roy DS, Zhang Y, Halassa MM, Feng G. Thalamic subnetworks as units of function. Nat Neurosci. 2022. doi:10.1038/s41593-021-00996-1
Publications
Labaki C, Bakouny Z, Sonpavde G, Choueiri TK, Van Allen EM. Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma. Eur Urol Oncol. 2022. doi:10.1016/j.euo.2022.01.004
DiCorpo D, LeClair J, Cole JB, et al. Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 individuals Across 13 Cohorts. Diabetes Care. 2022. doi:10.2337/dc21-1395
Stover EH, Oh C, Keskula P, et al. Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples. Prostate. 2022. doi:10.1002/pros.24305
Siewert-Rocks KM, Kim SS, Yao DW, Shi H, Price AL. Leveraging gene co-regulation to identify gene sets enriched for disease heritability. Am J Hum Genet. 2022. doi:10.1016/j.ajhg.2022.01.005
Pan J, Kwon JJ, Talamas JA, et al. Sparse dictionary learning recovers pleiotropy from human cell fitness screens. Cell Syst. 2022. doi:10.1016/j.cels.2021.12.005
Bagheri N, Carpenter AE, Lundberg E, Plant AL, Horwitz R. The new era of quantitative cell imaging-challenges and opportunities. Mol Cell. 2022;82(2):241-247. doi:10.1016/j.molcel.2021.12.024
Banskota S, Raguram A, Suh S, et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022;185(2):250-265.e16. doi:10.1016/j.cell.2021.12.021
Ursu O, Neal JT, Shea E, et al. Massively parallel phenotyping of coding variants in cancer with Perturb-seq. Nat Biotechnol. 2022. doi:10.1038/s41587-021-01160-7
Ludwig L, Lareau CA, Bao EL, et al. A Congenital Anemia Reveals Distinct Targeting Mechanisms for Master Transcription Factor GATA1. Blood. 2022. doi:10.1182/blood.2021013753